Comparison of protective effect of neutralizing antibody in serum and nasal secretions in experimental rhinovirus type 13 illness.
D000328:Adult; D000906:Antibodies / Q000032:analysis*; D000941:Antigens / Q000032:analysis; D003139:Common Cold / Q000276:immunology / Q000517:prevention & control*; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D009297:Nasal Mucosa / Q000378:metabolism*; D009500:Neutralization Tests; D012229:Rhinovirus / Q000472:pathogenicity; D014611:Vaccination; D014765:Viral Vaccines / Q000002:abnormalities*
D000906:Antibodies; D000941:Antigens; D014765:Viral Vaccines